Sol-Gel Technologies (SLGL) Competitors $0.55 +0.02 (+3.97%) Closing price 03/28/2025 03:57 PM EasternExtended Trading$0.56 +0.01 (+2.00%) As of 03/28/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLGL vs. STRO, VHAQ, MGX, QNCX, GANX, TNYA, ACHL, VOR, BYSI, and STTKShould you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Sutro Biopharma (STRO), Viveon Health Acquisition (VHAQ), Metagenomi (MGX), Quince Therapeutics (QNCX), Gain Therapeutics (GANX), Tenaya Therapeutics (TNYA), Achilles Therapeutics (ACHL), Vor Biopharma (VOR), BeyondSpring (BYSI), and Shattuck Labs (STTK). These companies are all part of the "pharmaceutical products" industry. Sol-Gel Technologies vs. Sutro Biopharma Viveon Health Acquisition Metagenomi Quince Therapeutics Gain Therapeutics Tenaya Therapeutics Achilles Therapeutics Vor Biopharma BeyondSpring Shattuck Labs Sutro Biopharma (NASDAQ:STRO) and Sol-Gel Technologies (NASDAQ:SLGL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment. Which has more risk and volatility, STRO or SLGL? Sutro Biopharma has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Sol-Gel Technologies has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Do analysts prefer STRO or SLGL? Sutro Biopharma presently has a consensus price target of $6.63, indicating a potential upside of 798.79%. Sol-Gel Technologies has a consensus price target of $5.00, indicating a potential upside of 809.09%. Given Sol-Gel Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sol-Gel Technologies is more favorable than Sutro Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sutro Biopharma 1 Sell rating(s) 5 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.22Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in STRO or SLGL? 97.0% of Sutro Biopharma shares are owned by institutional investors. Comparatively, 26.2% of Sol-Gel Technologies shares are owned by institutional investors. 5.9% of Sutro Biopharma shares are owned by company insiders. Comparatively, 66.5% of Sol-Gel Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media prefer STRO or SLGL? In the previous week, Sol-Gel Technologies had 1 more articles in the media than Sutro Biopharma. MarketBeat recorded 2 mentions for Sol-Gel Technologies and 1 mentions for Sutro Biopharma. Sutro Biopharma's average media sentiment score of 0.93 beat Sol-Gel Technologies' score of 0.43 indicating that Sutro Biopharma is being referred to more favorably in the media. Company Overall Sentiment Sutro Biopharma Positive Sol-Gel Technologies Neutral Is STRO or SLGL more profitable? Sutro Biopharma has a net margin of -77.01% compared to Sol-Gel Technologies' net margin of -81.75%. Sol-Gel Technologies' return on equity of -27.17% beat Sutro Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Sutro Biopharma-77.01% -101.89% -28.69% Sol-Gel Technologies -81.75%-27.17%-22.49% Does the MarketBeat Community believe in STRO or SLGL? Sol-Gel Technologies received 17 more outperform votes than Sutro Biopharma when rated by MarketBeat users. However, 64.08% of users gave Sutro Biopharma an outperform vote while only 63.40% of users gave Sol-Gel Technologies an outperform vote. CompanyUnderperformOutperformSutro BiopharmaOutperform Votes13264.08% Underperform Votes7435.92% Sol-Gel TechnologiesOutperform Votes14963.40% Underperform Votes8636.60% Which has stronger valuation & earnings, STRO or SLGL? Sol-Gel Technologies has lower revenue, but higher earnings than Sutro Biopharma. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Sutro Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSutro Biopharma$62.04M0.98-$106.79M-$3.02-0.24Sol-Gel Technologies$11.71M1.31-$27.24M-$0.34-1.62 SummarySol-Gel Technologies beats Sutro Biopharma on 11 of the 18 factors compared between the two stocks. Remove Ads Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLGL vs. The Competition Export to ExcelMetricSol-Gel TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.32M$6.90B$5.63B$7.83BDividend YieldN/A2.74%4.57%4.01%P/E Ratio-1.627.1723.3318.67Price / Sales1.31220.47388.3491.01Price / CashN/A65.6738.1634.64Price / Book0.336.396.894.23Net Income-$27.24M$142.12M$3.20B$247.15M7 Day Performance2.61%-5.06%-2.98%-2.17%1 Month Performance-17.92%-7.49%1.63%-5.68%1 Year Performance-43.88%-10.91%9.44%-0.74% Sol-Gel Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLGLSol-Gel Technologies2.4176 of 5 stars$0.55+4.0%$5.00+809.1%-45.5%$15.32M$11.71M-1.6250Upcoming EarningsShort Interest ↑Gap UpSTROSutro Biopharma4.2787 of 5 stars$0.77+0.4%$6.63+760.1%-87.0%$63.52M$62.04M-0.48240VHAQViveon Health AcquisitionN/A$11.00flatN/AN/A$62.26MN/A0.002High Trading VolumeMGXMetagenomi2.219 of 5 stars$1.65+0.6%$14.40+772.7%-86.0%$61.68M$52.30M-0.63236Analyst RevisionNews CoverageQNCXQuince Therapeutics2.3055 of 5 stars$1.40+1.4%$9.60+585.7%+27.4%$61.60MN/A-1.1360Earnings ReportAnalyst ForecastShort Interest ↓News CoverageGANXGain Therapeutics3.1913 of 5 stars$2.32-0.9%$8.20+253.4%-49.9%$61.54M$50,000.00-2.1120Earnings ReportAnalyst ForecastNews CoveragePositive NewsTNYATenaya Therapeutics4.1036 of 5 stars$0.70+10.0%$6.25+792.9%-87.7%$61.31MN/A-0.49110Short Interest ↓Analyst RevisionNews CoverageACHLAchilles Therapeutics2.9229 of 5 stars$1.48flat$4.00+170.3%N/A$60.83MN/A-0.90250Upcoming EarningsNews CoverageVORVor Biopharma2.4215 of 5 stars$0.88+1.7%$8.86+901.5%-68.2%$60.74MN/A-0.54140BYSIBeyondSpringN/A$1.55-3.1%N/A-59.7%$60.50M$1.88M0.0080News CoverageGap DownSTTKShattuck Labs2.5307 of 5 stars$1.24+3.3%$7.50+504.8%-88.2%$59.20M$6.44M-0.81100Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up Remove Ads Related Companies and Tools Related Companies Sutro Biopharma Alternatives Viveon Health Acquisition Alternatives Metagenomi Alternatives Quince Therapeutics Alternatives Gain Therapeutics Alternatives Tenaya Therapeutics Alternatives Achilles Therapeutics Alternatives Vor Biopharma Alternatives BeyondSpring Alternatives Shattuck Labs Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLGL) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
